VKH
SVA

Virtu KCG Holdings’s Sinovac Biotech, Ltd SVA Stock Holding History

Virtu KCG Holdings’s Portfolio SVA Stock Details SVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-17,731
Closed -$113K – 3728
2016
Q1 		$113K Buy
17,731
+7,651
+76% +$45.9K ﹤0.01% 2299
2015
Q4 		$58K Buy
+10,080
New +$54.3K ﹤0.01% 3126
2015
Q3 		– Sell
-17,720
Closed -$93K – 4360
2015
Q2 		$93K Buy
+17,720
New +$93.6K ﹤0.01% 2931
2014
Q4 		– Sell
-13,526
Closed -$65K – 4705
2014
Q3 		$65K Sell
13,526
-6,821
-34% -$36.6K ﹤0.01% 3293
2014
Q2 		$115K Sell
20,347
-27,329
-57% -$166K ﹤0.01% 3267
2014
Q1 		$343K Buy
+47,676
New +$316K ﹤0.01% 2374
2013
Q4 		– Sell
-26,837
Closed -$160K – 4733
2013
Q3 		$160K Buy
+26,837
New +$128K ﹤0.01% 3216

Other funds holding SVA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PRCM
Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Virtu KCG Holdings's SVA Position: Q2 2016 in Review

Virtu KCG Holdings sold out of Sinovac Biotech, Ltd (SVA) in Q2 2016, closing a stake of 17,731 shares — an estimated $113K sold.

Virtu KCG Holdings first reported a position in SVA in Q3 2013 and held it in 7 quarters. The position peaked at $343K in Q1 2014. 37 funds tracked by Wall St. Rank hold SVA as of Q2 2016.

  • Virtu KCG Holdings reported no remaining Sinovac Biotech, Ltd position as of Q2 2016 after selling out during the quarter.
  • Virtu KCG Holdings sold 17,731 Sinovac Biotech, Ltd shares in Q2 2016, an estimated $113K.
  • Virtu KCG Holdings first reported a position in Sinovac Biotech, Ltd in Q3 2013 and held it in 7 quarters.
  • Virtu KCG Holdings's Sinovac Biotech, Ltd position peaked at $343K in Q1 2014.
  • 37 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q2 2016.

Based on Virtu KCG Holdings's 13F filing for Q2 2016, filed 12 Aug 2016.